The Competition and Markets Authority has formally launched its Phase 1 investigation into McCormick & Company’s proposed acquisition of the majority of Unilever’s foods business, moving the transaction into substantive UK competition scrutiny.
The regulator notified the companies of the investigation on 16 September and has set 11 November as the deadline for its initial decision. It will determine whether the transaction creates a relevant merger situation and, if so, whether there is a realistic prospect of a substantial lessening of competition in any UK market.
The formal launch follows an earlier information-gathering process that began in July, when the CMA invited interested parties to comment on the proposed transaction. The deal subsequently moved through pre-notification while the regulator collected the information required to begin its statutory review.
McCormick & Company is a large international producer of herbs, spices, seasonings and flavour products, while the Unilever assets cover a portfolio of established food brands. The transaction would create a substantially larger international foods operation, making merger clearance an important condition of completion.
Phase 1 does not determine automatically whether a deal should be blocked. The CMA can clear the transaction, accept remedies where appropriate or refer it for a more detailed Phase 2 investigation if it identifies competition concerns that cannot be resolved during the initial process.
The review is likely to examine overlap at individual product-category level rather than simply comparing the total size of the two companies. Food groups frequently own broad portfolios in which competition can vary considerably between seasonings, sauces, packaged products and different customer channels.
Retail dynamics also matter. Branded manufacturers negotiate with major supermarkets and wholesalers while competing against retailer-owned alternatives. The effect of consolidation therefore depends partly on whether customers continue to have credible suppliers and whether private-label products provide sufficient competitive pressure.
Competition authorities increasingly examine bargaining power and innovation alongside direct price effects. Combining two portfolios can influence promotional spending, product development and negotiations with distributors even where supermarket shelves continue to carry many individual brands.
The regulatory timetable has direct financial consequences for the transaction. Deal agreements normally allow time for merger clearances, but prolonged review can increase financing costs and delay integration. Where regulators identify problems, companies may need to offer divestments or other commitments before completion.
An 11 November Phase 1 deadline gives both sides a defined UK milestone. It does not guarantee completion at that point: a referral would move the transaction into a substantially longer process, while a clearance would remove one major source of execution risk.
The inquiry arrives as large consumer and food groups continue to reassess portfolios. Brand owners have been selling divisions, concentrating resources on higher-growth categories and pursuing acquisitions that offer greater scale in selected markets. That strategic logic remains separate from the CMA’s task, which is to assess the effect on competition.
For customers and suppliers, market structure can influence negotiating leverage as much as consumer-facing prices. Larger manufacturers can gain procurement efficiencies and wider distribution, but they can also become more important counterparties for retailers and smaller suppliers.
The UK review will therefore turn on evidence about individual markets rather than the companies’ broader global strategies. The CMA’s November decision will establish whether those questions can be resolved within Phase 1 or require a deeper examination before McCormick can complete the acquisition.
You must be logged in to post a comment.